Page last updated: 2024-10-15
deoxydiguanosine diphosphosphate
Description
5'-d(pGpG)-3' : A single-stranded DNA oligonucleotide comprising two 2'-deoxyguanosine residues connected by a 3'->5 linkage and with a phosphoric group at the 5'-terminus. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
Synonyms (16)
| Synonym |
|---|
| deoxydiguanosine diphosphosphate |
| deoxy(5'-guanylyl-3'-guanylic acid) |
| 26467-04-9 |
| 5'-guanylic acid, 2'-deoxyguanylyl-(5'-3')-2'-deoxy- |
| d(pgpg) |
| dpg-g |
| dpgdpg |
| pdgpdg |
| 2'-deoxyguanylyl-(5'->3')-2'-deoxy-5'-guanylic acid |
| dpg-dpg |
| d(pg-g) |
| 5'-d(pgg)-3' |
| 5'-d(pgpg)-3' |
| CHEBI:76403 |
| DTXSID00181065 |
| Q27145955 |
Roles (1)
| Role | Description |
|---|
| Mycoplasma genitalium metabolite | Any bacterial metabolite produced during a metabolic reaction in Mycoplasma genitalium. |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (2)
| Class | Description |
|---|
| single-stranded DNA oligonucleotide | An oligonucleotide that is a fragment of a larger single-stranded DNA molecule (either naturally occurring or synthetic). Phosphono groups may or may not be present at the 3'- and 5'- termini. |
| 5'-phospho-(3'->5')-dinucleotide | |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (8)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |